Monoclonal antibody therapy is administered intravenously (into a vein). It is usually given as an infusion, which means the antibody is slowly injected over a period of time. Infusions can last anywhere from 30 minutes to several hours, depending on the type and dose of antibody being used.
What are the side effects of monoclonal antibody therapy?
Most people do not experience any serious side effects from monoclonal antibody therapy. However, as with any treatment, there is a small risk of developing an allergic reaction to the antibody. Symptoms of an allergic reaction may include difficulty breathing, hives, and swelling of the face, lips, or tongue. If you experience any of these symptoms, seek medical attention immediately.
What are the benefits of monoclonal antibody therapy?
Monoclonal antibody therapy is a very effective treatment for a number of conditions, including cancer, autoimmune disorders, and infections. It can be used to treat a wide variety of cancers, including breast, colon, lung, and ovarian cancer. It is also used to treat autoimmune disorders such as rheumatoid arthritis and Crohn’s disease. Additionally, monoclonal antibody therapy is used to treat infections, such as hepatitis C and HIV.
What are the risks of monoclonal antibody therapy?
There are a few risks associated with monoclonal antibody therapy. As with any treatment, there is a small risk of developing an allergic reaction to the antibody. Additionally, monoclonal antibody therapy can cause a temporary drop in blood pressure, which can cause dizziness or lightheadedness. Finally, monoclonal antibody therapy can cause a small increase in the risk of developing infections. However, the benefits of monoclonal antibody therapy far outweigh the risks.